Case presentation {#Sec1}
=================

A 30-year-old Japanese male, a smoker with no significant past medical, allergy or cocaine use history, developed chills, cough and dyspnea a few minutes after using a fluoropolymer-based waterproofing spray on his leather uniforms in a small closed room. He presented to our hospital 1 h later. Examination revealed that the patient had incessant cough, tachypnea (30 breaths per minute), fever (39.4°C) and slightly decreased peripheral arterial oxygen saturation \[percutaneous oxygen saturation (SpO~2~): 92% on room air\]; however, there were no lung crackles or wheeze. Examination of the cardiovascular system revealed no abnormalities. There was no weight loss, arthralgia or skin rash. As shown in Table [1](#Tab1){ref-type="table"}, the blood tests revealed leukocytosis \[20,300 cells/μL (normal, 4,000--8,000 cells/μL) with 91.5% neutrophils, 0% eosinophils and 6.5% lymphocytes\], elevated serum C-reactive protein levels \[3.14 mg/dL (normal, \<0.3 mg/dL)\] and elevated serum LDH levels \[341 U/l (normal, 106--220 U/l)\]. Autoimmune screening, including for anti-neutrophil cytoplasm antibody (ANCA) and anti-glomerular basement membrane (anti-GBM) antibody, revealed no autoantibodies. The serum brain natriuretic peptide (BNP) level and coagulation profile were normal. Urinalysis showed no proteinuria or hematuria. Chest radiographs and computed tomography (CT) scan showed bilateral ground glass opacities, mainly in the upper lobes (Figure [1](#Fig1){ref-type="fig"}). Fiberoptic bronchoscopy was performed 13 h after the onset of the symptoms. Bronchoalveolar lavage (BAL) fluid obtained from the right middle lobe showed a bloody appearance (Figure [2](#Fig2){ref-type="fig"}, left). While the upper lobes appeared to be predominantly involved, the middle lobe was selected for obtaining the BAL sample, because this lobe is the smallest and yields the largest return (Baughman [@CR1]). Microscopic examination of a BAL cytospin specimen revealed the presence of numerous red blood cells with extreme neutrophilia (differential neutrophil count 79.8%, normal range \<3%) (Figure [2](#Fig2){ref-type="fig"}, right). The siderophage count was less than 2%. Microbiological studies of the BAL fluid were negative. The patient was observed without corticosteroid therapy, and his symptoms improved significantly by the day after admission. By day 7 after admission, the abnormal shadows on the chest radiographs and CT scan had almost completely disappeared and the patient was discharged from the hospital. At 6 months after discharge, his health status was normal. Consent to publish this case report was obtained from the patient.Table 1Laboratory data on admissionHematology White blood cells20,300/μl (H)  Neutrophils91.5% (H)  Eosinophils0.0%  Basophils0.0%  Lymphocytes6.5%  Monocytes2.0% Hemoglobin16.5 g/dl Platelets273,000/μlBiochemistry Total protein7.0 g/dl Albumin4.6 g/dl Blood urea nitrogen11.5 mg/dl Creatinine0.97 mg/dl Lactate dehydrogenase341 U/l (H) Aspartate aminotransferase26 U/l Alanine aminotransferase12 U/lCoagulation PT-INR1.06 APTT29.5 s APTT (control)34.0 sSerology C-reactive protein3.14 mg/dl (H) KL-6339 U/ml Surfactant protein-D17.2 ng/ml B-D-glucan\<6.0 pg/ml Brain natriuretic peptide10.2 pg/ml Anti-GBM antibody\<10 U/ml Antinuclear antibody\<×40 Anti-ds-DNA antibody\<1.2 IU/ml Anti-SS-A antibody\<1.0 U/ml Anti-SS-B antibody\<1.0 U/ml Anti-Scl-70 antibody\<1.0 U/ml Anti-Jo-1 antibody− MPO-ANCA\<1.0 U/ml PR3-ANCA\<1.0 U/mlUrinalysis Protein− Sugar− Occult blood--Bronchoalveolar lavage (rt.B^4^a) Recovery rate53.3% (80/150 ml) Cell count1.2 × 10^6^/μl Macrophages20.0% Lymphocytes0.8% Eosinophils0.4% Neutrophils78.8% (H) Siderophages1.9%Culture Bacteria− Mycobacterium tuberculosis− CytologyClass II*PT-INR* prothrombin time-international normalized ratio, *APTT* activated partial thromboplastin time, *KL-6* sialylated carbohydrate antigen KL-6, *anti-GBM antibody* anti-anti-glomerular basement membrane antibody, *anti-ds-DNA antibody* anti-double stranded DNA, *anti-SS-A antibody* anti-Sjögren's-syndrome-related antigen A antibody, *anti-SS-B antibody* anti-Sjögren's-syndrome-related antigen B antibody, *anti-Scl-70 antibody* anti-scleroderma-70 antibody, *anti-Jo-1 antibody* anti-histidyl tRNA synthetase antibody, *MPO-ANCA* myeloperoxidase-antineutrophil cytoplasmic antibody, *PR3-ANCA* proteinase 3- antineutrophil cytoplasmic antibody, *H* indicates high, *−* indicates negative.Figure 1A radiograph (*left*) and high resolution CT scan (*right*) of the chest showing bilateral ground glass opacities.Figure 2Bloody gross appearance (*left*) and microscopic findings (*right*) of bronchoalveolar lavage fluid specimens. *Right* May-Giemsa-stained cytospin preparation showing numerous red blood cells and neutrophils, consistent with the diagnosis of alveolar hemorrhage. *Arrows* macrophages. *Scale bar* 50 μm.

Discussion {#Sec2}
==========

Accidental inhalation of waterproofing spray has been reported to cause lung injury (Vernez et al. [@CR7]). Diffuse alveolar hemorrhage (DAH) is a rare, but serious manifestation of acute lung injury (Fukui et al. [@CR4]). DAH in this patient was unlikely to be due to immune causes such as microscopic polyangiitis, systemic lupus erythematosus or Goodpasture's syndrome, because of the absence of weight loss, arthralgia, proteinuria, hematuria, anti-nuclear antibody, anti--anti-GBM antibody or ANCA (Picard et al. [@CR6]). Furthermore, neither congestive heart failure nor coagulopathy could be considered as the likely cause of the DAH, because the serum BNP level and coagulation profile were normal.

The toxicity of waterproofing sprays is thought to be due to their content of water-repellents, such as fluoropolymers and silicon polymers, or of the solvent in which they are delivered (Picard et al. [@CR6]). Among different repelling agents, fluoropolymers have been the most studied with regard to their toxicity following inhalation (Hays and Spiller [@CR5]). An animal study in mice demonstrated that inhalation of fluoropolymers resulted in pulmonary collapse and pneumonia, probably by counteracting the surfactant action in the alveoli of the lung, whereas mice exposed to non-fluoropolymer-containing products showed less severe injury (Yamashita and Tanaka [@CR8]). These findings suggest that the fluoropolymer water repellents in waterproofing sprays are responsible for causing the acute respiratory illness following inhalation. The primary structural changes after inhalation of waterproofing sprays in animals include alveolar type I cell necrosis and alveolar type II cell necrosis, with resultant impairment of surfactant secretion, direct counteraction of surfactant action, alveolar atelectasis and hemorrhage (Hays and Spiller [@CR5]). A recent study reported developing an isolated perfused rat lung model to examine the potential of surface tension-active substances in waterproofing sprays to cause pulmonary collapse (Fischer et al. [@CR3]). Other mechanisms of the toxicity of waterproofing sprays include an indirect and complex mechanism requiring metabolic activation with or without interaction with other factors, such as solvents (e.g., n-heptane, hexane and petroleum distillates) and smoking (Hays and Spiller [@CR5]). The mist particle size and the emission rate have also been shown to influence the toxicity of waterproofing sprays (Hays and Spiller [@CR5]; Yamashita et al. [@CR9]).

The commonest symptoms associated with inhalation of fluoropolymer-based waterproofing sprays include non-productive cough and dyspnea, often accompanied by flu-like symptoms (Vernez et al. [@CR7]; Hays and Spiller [@CR5]). The illness develops rapidly, usually within minutes to hours (Vernez et al. [@CR7]; Hays and Spiller [@CR5]). Similar to the case reported herein, there is one previous report of DAH resulting from inhalation of a waterproofing spray (Fukui et al. [@CR4]). Laboratory studies generally reveal evidence of acute inflammation such as leukocytosis and elevated serum CRP (Hays and Spiller [@CR5]). In one previous case report, marked hypocalcemia was observed in the patient, which was attributed to the binding activity of fluoride to cations, such as calcium (Bracco and Favre [@CR2]). Serious outcomes and death are uncommon (Vernez et al. [@CR7]; Hays and Spiller [@CR5]). Most victims, even those that present DAH, like our patient, improved with supportive care, with or without corticosteroid and inhaled β~2~ adrenergic agonist therapy (Vernez et al. [@CR7]; Fukui et al. [@CR4]; Hays and Spiller [@CR5]).

Conclusions {#Sec3}
===========

Accidental inhalation of waterproofing sprays may cause diffuse alveolar hemorrhage, a rare manifestation of acute lung injury. Supportive treatment may be effective and sufficient.
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